USITC Votes To Continue Investigations On Hexamine (Hexamethylenetetramine)

November 13, 2024

News Release 24-110

Inv. No(s). 701-TA-737-738, 731-TA-1712 -1715

Contact: Jennifer Andberg , 202-205-1819

USITC Votes To Continue Investigations On Hexamine (Hexamethylenetetramine)

The U.S. International Trade Commission (Commission) today determined that there is a reasonable indication that a U.S. industry is materially injured or threatened with material injury by reason of imports of hexamine (hexamethylenetetramine) from China, Germany, India, and Saudi Arabia that are allegedly sold in the United States at less than fair value and subsidized by the governments of China and India.

Chair Amy A. Karpel and Commissioners Jason E. Kearns, David S. Johanson and Rhonda K. Schmidtlein voted in the affirmative.

As a result of the Commission’s affirmative determinations, the U.S. Department of Commerce will continue its investigations of imports of hexamine from China, Germany, India, and Saudi Arabia, with its preliminary antidumping duty determinations for China, Germany, India, and Saudi Arabia due on or about March 10, 2025 and its preliminary countervailing duty determinations for China and India on December 26, 2024.

The Commission’s public report Hexamine (Hexamethylenetetramine) from China, Germany, India, and Saudi Arabia, (Inv. Nos. 701-TA-737-738 and 731-TA-1712-1715 (Preliminary), USITC Publication 5563 (November 2024) will contain the views of the Commission and information developed during the investigations.

The report will be available by December 11, 2024; when available, it may be accessed on the USITC website at: https://www.usitc.gov/commission_publications_library.

# # #